Skip to main content

Table 1 Baseline Characteristics on Hospital Admission

From: Clinical characteristics and outcomes of critically ill COVID-19 patients in Tokyo: a single-center observational study from the first wave

Variable

 

Range

Age, years

57.5 (49.0, 69.8)

30–85

Male

19 (79)

 

BMI, kg/m2

24.7 (22.3, 28.2)

19.4–35.4

 Underweight (BMI < 18.5)

0 (0)

 

 Normal (18.5 ≤ BMI < 25)

13 (54)

 

 Overweight (25 ≤ BMI < 35)

7 (29)

 

 Obese (35 ≤ BMI)

4 (17)

 

Comorbidities

 Hypertension

8 (33)

 

 Diabetes

7 (29)

 

 Coronary artery disease

2 (8)

 

 Asthma

6 (25)

 

 Chronic obstructive pulmonary disease

3 (13)

 

 Hyperuricemia

4 (17)

 

 Malignancy

2 (8)

 

 Others*

4 (17)

 

Current or former smoker

16 (67)

 

Habitual or occasional alcohol consumption

11 (58)

 

Symptoms

 Fever

23 (96)

 

 Dyspnea

17 (71)

 

 Myalgia

4 (17)

 

 Diarrhea

6 (25)

 

Vital signs

 Body temperature†, degrees Celsius

37.7 (37.1, 38.2)

36.2–39.5

 Heart rate, beats per minute

98 (94, 115)

66–133

 Respiratory rate, per minute

24 (20, 30)

14–44

 SpO2‡, %

92 (88, 94)

66–97

Laboratory data

 White blood cell count, /mm3

7250 (4975, 8950)

3200–19,900

 Neutrophil to lymphocyte ratio

10.1 (5.1, 20.1)

2.5–62.0

 Platelet count, ×104 /μL

17.4 (15.6, 22.3)

120–389

 Lactic acid dehydrogenase, U/L

383 (315, 496)

214–1002

 Aspartate aminotransferase, U/L

49.0 (36.5, 68.5)

46.0–97.0

 Alanine aminotransferase, U/L

34.0 (27.5, 50.5)

16.0–85.0

 Creatinine kinase, U/L

152 (56, 357)

17–2663

 C-reactive protein, mg/dL

10.5 (7.4, 16.0)

0.9–33.8

 D-dimer, μg/mL

1.2 (1.0, 9.9)

0.5–25.7

  1. BMI body mass index, SpO2 percutaneous pulse saturation
  2. Missing data: Habitual or occasional alcohol consumption, 5; SpO2, 5
  3. Data are expressed as numbers (percentage) or median (interquartile range)
  4. *Rheumatoid arthritis, hyperthyroidism, ulcerative colitis, and a past history of pulmonary embolism were present in one patient each, respectively
  5. †Body temperature measurements were all axillary
  6. ‡Includes measurements with room air inhalation. Initial SpO2 measurements under the influence of oxygen inhalation were excluded